Hanneke C. Kluin‐Nelemans
0000-0003-2617-9427
Publication & Citation Trends
Publications
583 total
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study OA
Cited by 7
Semantic Scholar
BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma OA
Cited by 1
Semantic Scholar
Relationships, marriage, and partner abandonment among Hodgkin lymphoma survivors treated in nine EORTC-GELA Lymphoma Group trials
Cited by 0
Semantic Scholar
Concordance between late effects reported by physicians and patients in a cohort of long-term Hodgkin lymphoma survivors: an analysis of data from nine consecutive EORTC-LYSA trials.
Cited by 0
Semantic Scholar
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM OA
Cited by 4
Semantic Scholar
Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials OA
Cited by 16
Semantic Scholar
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry
Cited by 11
Semantic Scholar
Induction and Maintenance Therapy in Elderly Patients with Mantle Cell Lymphoma: Double-Randomized MCL R2 Elderly Clinical Trial By the European Mantle Cell Lymphoma Network OA
Cited by 8
Semantic Scholar
Research Topics
Lymphoma Diagnosis and Treatment
(213)
Chronic Lymphocytic Leukemia Research
(128)
Mast cells and histamine
(82)
Viral-associated cancers and disorders
(67)
Immune Cell Function and Interaction
(39)
Affiliations
Leiden University
European Organisation for Research and Treatment of Cancer
Tufts Medical Center
Apple (Israel)
Royal Marsden NHS Foundation Trust